Back to results
US 2026/0248788 A1Published application
New compounds and treatment of renal cell carcinoma
AssigneeTrustlife Therapeutics Inc.
InventorsAdil MARDINOGLU, Xiangyu LI, Younos BOUZIAN, Mohamed EL HAFI, Negar PARVIZI
Life of this patent
Estimating the term…
Abstract
There is provided a compound according to formula (I), or a pharmaceutically acceptable salt or prodrug thereof.
Claims8
A compound according to any of the following formulas
- or a pharmaceutically acceptable salt or prodrug thereof.
2-11. (canceled)
Dependencies are inferred from the claim text.